Cargando…
Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
BACKGROUND: Hepatitis C virus (HCV) infection and its treatments are associated with significant symptoms, side effects and impact on patients functioning. The Hepatitis C Symptom and Impact Questionnaire version 4 (HCV-SIQv4) was developed according to FDA Patient Reported Outcomes (PRO) Guidance,...
Autores principales: | Trigg, Andrew, Chan, Eric, Kitchen, Helen, Willgoss, Tom, Ho, Kai Fai, Pierson, Renee, Scott, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299472/ https://www.ncbi.nlm.nih.gov/pubmed/32685576 http://dx.doi.org/10.36469/9675 |
Ejemplares similares
-
Simeprevir for the treatment of hepatitis C virus infection
por: Izquierdo, Laure, et al.
Publicado: (2014) -
Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
por: Gaeta, Giovanni Battista, et al.
Publicado: (2018) -
For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015) -
Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study
por: Alam, Imtiaz, et al.
Publicado: (2016) -
New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
por: Kanda, Tatsuo, et al.
Publicado: (2014)